Key Segments:
By Product
-
-
Enzymes
-
Glycosidases
-
Neuraminidases
-
Glycosyltransferases
-
Sialyltransferases
-
Others
-
-
Kits
-
Glycan Labeling Kits
-
Glycan Purification Kits
-
Glycan Release Kits
-
Others
-
-
Reagents
-
Glycoproteins
-
Monosaccharides
-
Oligosaccharides
-
Others
-
-
Instruments
-
Mass Spectrometers
-
HPLC
-
MALDI-TOF
-
Array Systems
-
Others
-
-
By Application
-
-
Drug Discovery & Development
-
Diagnostics
-
Others
-
By End-use
-
-
Academic & Research Institutes
-
Pharmaceutical & Biotechnology Companies
-
Biopharmaceutical Companies
-
CROs
-
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
-
Mexico
Europe
-
Eastern Europe
-
Poland
-
Romania
-
Hungary
-
Turkey
-
Rest of Eastern Europe
-
-
Western Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Netherlands
-
Switzerland
-
Austria
-
Rest of Western Europe
-
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Vietnam
-
Singapore
-
Australia
-
Rest of Asia Pacific
Middle East & Africa
Middle East
-
UAE
-
Egypt
-
Saudi Arabia
-
Qatar
-
Rest of the Middle East
Africa
-
Nigeria
-
South Africa
-
Rest of Africa
Latin America
-
Brazil
-
Argentina
-
Colombia
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Product Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Product Matrix which gives a detailed comparison of the product portfolio of each company
-
Geographic Analysis
-
Additional countries in any of the regions
-
Company Information
-
Detailed analysis and profiling of additional market players (Up to five)
Frequently Asked Questions
Europe is expected to grow at a CAGR of 15.43%, driven by increased research funding, innovation in diagnostics, and a focus on personalized medicine.
North America led the market with a 43% revenue share.
Enzymes were the top revenue-generating product, with a 34% market share in 2023.
Glycomics plays a critical role in drug discovery, diagnostics, and personalized medicine, enhancing the understanding of glycans in health and disease.
Glycomics Market was valued at USD 1.68 billion in 2023 and is expected to reach USD 5.33 billion by 2032, growing at a CAGR of 13.76% from 2024-2032.